Max Robotics — Global Service Robot Directory + US Certification

About

M Fujimura is a leading urologic oncologist whose research focuses on advancing surgical outcomes for bladder cancer, particularly through the integration of robotic technology and enhanced recovery protocols. His most impactful work examines the advantages of enhanced recovery after surgery (ERAS) programs in robot-assisted radical cystectomy (RARC), a gold-standard treatment for muscle-invasive bladder cancer. By comparing perioperative outcomes between RARC with ERAS and traditional open radical cystectomy, Fujimura demonstrated that the combined approach significantly reduces hospital stays, accelerates recovery, and minimizes complications without compromising oncologic efficacy. This landmark study, published in 2023 and already cited 9 times, has helped establish ERAS as a critical component of modern robotic cystectomy, influencing clinical guidelines worldwide. Fujimura’s contributions bridge the gap between surgical innovation and patient-centered care, offering bladder cancer patients faster, safer recoveries. His work continues to shape the evolution of minimally invasive urologic surgery, making him a key figure in the field’s shift toward optimized perioperative management.